Discover Insmed's innovative therapies targeting rare diseases, with approvals like Brinsupri boosting potential.

Last week, PureTech Health spun out a new company, Celea Therapeutics, which will develop its pulmonary fibrosis candidate ...

These 10 large-cap stocks gained this week, some due to positive news such as media rights deals or FDA approvals.